«We increased
median survival time in animals by 40 %, which gives us enough evidence to go on to human clinical trials,» Belcher says.
Not exact matches
Brahmer emphasizes that the relatively small increase
in median survival time with the use of the new immunotherapy drugs may be somewhat misleading
in terms of overall impact of the medicines.
A follow - up of the 48 patients who were evaluable at a
median time of 24 months indicated no statistical differences between the two groups
in terms of overall or progression - free
survival.
Of the dogs stricken with osteosarcoma, 35 had the cancer
in a leg which was subsequently amputated, followed by chemotherapy, which is the standard - of - care treatment; the dogs with elevated total cholesterol had a
median survival time of 455 days, more than 200 days greater than the
median survival time for dogs with normal cholesterol.
The team found that patients with more varied types of bacteria
in their digestive tract had longer
median progression - free
survival, defined at the
time point where half of studied patients have their disease progress.
The researchers then tested their scoring method using data on 688 AML patients
in three different clinical trials, In each of these groups, patients with low scores (methylation patterns similar to normal HSCs) had approximately twice the median survival time of patients with high score
in three different clinical trials,
In each of these groups, patients with low scores (methylation patterns similar to normal HSCs) had approximately twice the median survival time of patients with high score
In each of these groups, patients with low scores (methylation patterns similar to normal HSCs) had approximately twice the
median survival time of patients with high scores.
Those that got Photofrin either intravenously or encapsulated
in nanoparticles had a
median survival time of 13 days.
Sweeney said more
time is needed to assess the benefit of the drug combination
in the men with lesser burdens of disease, as their
median survival has not yet been reached.
The tumors grew rapidly
in the control experiments (the
median time for tumor - free
survival was one week) and any differences
in tumor - free
survival for the controls and the mice injected with cells expressing mutated PREX2 were not statistically significant (Horrigan et al., 2017).
Although researchers found that delivering the Isis drug directly into the brain nearly doubled
survival time in a mouse model of SMA3, systemic administration
in the rodents — which usually die within two weeks — has been shown to extend
median survival by up to eight months.
Median overall survival, commonly referred to as median OS, is the time point at which 50 % of patients in a trial are expected to have sur
Median overall
survival, commonly referred to as
median OS, is the time point at which 50 % of patients in a trial are expected to have sur
median OS, is the
time point at which 50 % of patients
in a trial are expected to have survived.
When that number is over 70 mg / dL, the
median survival time of the 24 dogs
in one study was, unfortunately, only 30 days.
In one study,
median survival time was 118 days for dogs with evidence of tumor invasion of other local organs compared with 218 days for dogs with no evidence of invasion beyond the urinary bladder.
In general, dogs with meningiomas have a
median survival time of 1 - 2 years.
Dogs
in the standard - dose and low - dose pimobendan groups had significantly longer
median survival times than dogs
in the conventional group (334, 277 and 136 days, respectively; P < 0.001).
According to the Ohio State University Veterinary Medical Center's webpage on mammary cancer, cats with tumors more than 3 cm
in diameter have a
median survival time of 4 to 6 months, cats with tumors 2 to 3 cm
in diameter have a typical life expectancy of about two years, and cats with tumors less than 2 cm
in diameter generally survive more than three years.
Prognosis — Conventional chemotherapy results
in total remission
in approximately 60 - 90 % of cases with a
median survival time of 6 - 12 months.
Monitoring for bone marrow suppression is needed with a medication this strong, but
in one study with 10 affected dogs all were able to achieve remission and
median survival time was 531 days.
Dogs with tumors less than or equal to 3 cm
in diameter prior to surgery had a
median survival time of 31 months.
However,
in a separate study, 35 % of dogs benefited from piroxicam and mitoxantrone and showed a
median survival time of 291 days.
Tumors removed when they are less than 0.8 inches (2 cm)
in diameter have a
median survival time of 4.5 years.
In the 50 % of cats that showed at least some response to therapy, median survival time increased to 150 to 180 days as opposed to 75 to 86 days in the 50 % that did not respon
In the 50 % of cats that showed at least some response to therapy,
median survival time increased to 150 to 180 days as opposed to 75 to 86 days
in the 50 % that did not respon
in the 50 % that did not respond.
But
in case of oral metastasis, the
median survival time has been estimated at 16 - 24 months.
In the 50 % of cats that showed at least some response to therapy, median survival time increased to 150 - 180 days as opposed to 75 - 86 days in the 50 % that did not respon
In the 50 % of cats that showed at least some response to therapy,
median survival time increased to 150 - 180 days as opposed to 75 - 86 days
in the 50 % that did not respon
in the 50 % that did not respond.
I can't recall seeing a study that gave a
median or average
survival time for this condition but my impression is that you are basically correct
in your assessment of the how well steroids work.